Literature DB >> 28971873

New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis.

Christopher T Lohans1, Jürgen Brem2, Christopher J Schofield2.   

Abstract

Entities:  

Keywords:  antibiotic resistance; avibactam; aztreonam; beta-lactamases; metalloenzymes; monobactams

Mesh：

Substances：

Year:  2017        PMID： 28971873      PMCID： PMC5700305          DOI： 10.1128/AAC.01224-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers.

Authors:  Jared L Crandon; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

Review 2.  The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.

Authors:  T R Walsh
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

3.  Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases.

Authors:  C Prosperi-Meys; G Llabres; D de Seny; R P Soto; M H Valladares; N Laraki; J M Frere; M Galleni
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

Review 4.  Antibiotics in late clinical development.

Authors:  Prabhavathi Fernandes; Evan Martens
Journal:  Biochem Pharmacol       Date:  2016-09-26       Impact factor: 5.858

5.  Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Authors:  Steven Marshall; Andrea M Hujer; Laura J Rojas; Krisztina M Papp-Wallace; Romney M Humphries; Brad Spellberg; Kristine M Hujer; Emma K Marshall; Susan D Rudin; Federico Perez; Brigid M Wilson; Ronald B Wasserman; Linda Chikowski; David L Paterson; Alejandro J Vila; David van Duin; Barry N Kreiswirth; Henry F Chambers; Vance G Fowler; Michael R Jacobs; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.

Authors:  Anaïs Potron; Emilie Rondinaud; Laurent Poirel; Olivier Belmonte; Sophie Boyer; Sabine Camiade; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2013-01-08       Impact factor: 5.283

8.  Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.

Authors:  José-Manuel Rodríguez-Martínez; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

9.  Monitoring conformational changes in the NDM-1 metallo-β-lactamase by 19F NMR spectroscopy.

Authors:  Anna M Rydzik; Jürgen Brem; Sander S van Berkel; Inga Pfeffer; Anne Makena; Timothy D W Claridge; Christopher J Schofield
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-24       Impact factor: 15.336

10.  Interaction of Avibactam with Class B Metallo-β-Lactamases.

Authors:  Martine I Abboud; Christian Damblon; Jürgen Brem; Nicolas Smargiasso; Paola Mercuri; Bernard Gilbert; Anna M Rydzik; Timothy D W Claridge; Christopher J Schofield; Jean-Marie Frère
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191
View more
  11 in total

Review 1.  Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

Authors:  Krisztina M Papp-Wallace; Andrew R Mack; Magdalena A Taracila; Robert A Bonomo
Journal:  Infect Dis Clin North Am       Date:  2020-09-30       Impact factor: 5.982

2.  A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).

Authors:  Pei W Thomas; Michael Cammarata; Jennifer S Brodbelt; Arthur F Monzingo; R F Pratt; Walter Fast
Journal:  Biochemistry       Date:  2019-06-07       Impact factor: 3.162

3.  Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors.

Authors:  Jürgen Brem; Tharindi Panduwawala; Jon Ulf Hansen; Joanne Hewitt; Edgars Liepins; Pawel Donets; Laura Espina; Alistair J M Farley; Kirill Shubin; Gonzalo Gomez Campillos; Paula Kiuru; Shifali Shishodia; Daniel Krahn; Robert K Leśniak; Juliane Schmidt Adrian; Karina Calvopiña; María-Carmen Turrientes; Madeline E Kavanagh; Dmitrijs Lubriks; Philip Hinchliffe; Gareth W Langley; Ali F Aboklaish; Anders Eneroth; Maria Backlund; Andrei G Baran; Elisabet I Nielsen; Michael Speake; Janis Kuka; John Robinson; Solveiga Grinberga; Lindsay Robinson; Michael A McDonough; Anna M Rydzik; Thomas M Leissing; Juan Carlos Jimenez-Castellanos; Matthew B Avison; Solange Da Silva Pinto; Andrew D Pannifer; Marina Martjuga; Emma Widlake; Martins Priede; Iva Hopkins Navratilova; Marek Gniadkowski; Anna Karin Belfrage; Peter Brandt; Jari Yli-Kauhaluoma; Eric Bacque; Malcolm G P Page; Fredrik Björkling; Jonathan M Tyrrell; James Spencer; Pauline A Lang; Pawel Baranczewski; Rafael Cantón; Stuart P McElroy; Philip S Jones; Fernando Baquero; Edgars Suna; Angus Morrison; Timothy R Walsh; Christopher J Schofield
Journal:  Nat Chem       Date:  2021-12-13       Impact factor: 24.427

Review 4.  β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.

Authors:  Montserrat Mora-Ochomogo; Christopher T Lohans
Journal:  RSC Med Chem       Date:  2021-08-04

5.  Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans.

Authors:  Michiyoshi Nukaga; Michael J Yoon; Magdalena A Taracilia; Tyuji Hoshino; Scott A Becka; Elise T Zeiser; Joseph R Johnson; Krisztina M Papp-Wallace
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

Review 6.  Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.

Authors:  Matthias Gerhard Vossen; Christopher Milacek; Florian Thalhammer
Journal:  ESMO Open       Date:  2018-06-13

Review 7.  Will morphing boron-based inhibitors beat the β-lactamases?

Authors:  Alen Krajnc; Pauline A Lang; Tharindi D Panduwawala; Jürgen Brem; Christopher J Schofield
Journal:  Curr Opin Chem Biol       Date:  2019-04-18       Impact factor: 8.972

8.  Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases.

Authors:  Alen Krajnc; Jürgen Brem; Philip Hinchliffe; Karina Calvopiña; Tharindi D Panduwawala; Pauline A Lang; Jos J A G Kamps; Jonathan M Tyrrell; Emma Widlake; Benjamin G Saward; Timothy R Walsh; James Spencer; Christopher J Schofield
Journal:  J Med Chem       Date:  2019-09-16       Impact factor: 7.446

Review 9.  β-Lactamases and β-Lactamase Inhibitors in the 21st Century.

Authors:  Catherine L Tooke; Philip Hinchliffe; Eilis C Bragginton; Charlotte K Colenso; Viivi H A Hirvonen; Yuiko Takebayashi; James Spencer
Journal:  J Mol Biol       Date:  2019-04-05       Impact factor: 5.469

10.  Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.

Authors:  Marcus Hong; Hissa Al-Farsi; Anna Olsson; Christian G Giske; Pernilla Lagerbäck; Thomas Tängdén
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.